Adient (ADNT)
(Delayed Data from NYSE)
$22.33 USD
+0.17 (0.77%)
Updated Aug 28, 2024 04:00 PM ET
After-Market: $22.33 0.00 (0.00%) 7:36 PM ET
5-Strong Sell of 5 5
A Value C Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$22.33 USD
+0.17 (0.77%)
Updated Aug 28, 2024 04:00 PM ET
After-Market: $22.33 0.00 (0.00%) 7:36 PM ET
5-Strong Sell of 5 5
A Value C Growth D Momentum B VGM
Zacks News
Adient (ADNT) Q3 Earnings Miss Estimates, Guidance Trimmed
by Zacks Equity Research
Adient (ADNT) reports lower-than-expected fiscal third-quarter results and expects fiscal 2024 revenues to be $14.6 billion, down from the previous guidance of $14.80-$14.90 billion.
Compared to Estimates, Adient (ADNT) Q3 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Adient (ADNT) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Adient (ADNT) Q3 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Adient (ADNT) delivered earnings and revenue surprises of -52.24% and 2.53%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Dana (DAN) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Dana (DAN) delivered earnings and revenue surprises of 29.17% and 1.66%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Adient (ADNT) Q3 Earnings Expected to Decline
by Zacks Equity Research
Adient (ADNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for July 1st
by Zacks Equity Research
ADNT, ARCB and GEO have been added to the Zacks Rank #5 (Strong Sell) List on July 1, 2024.
New Strong Sell Stocks for June 25th
by Zacks Equity Research
ARR, ADNT and USAS have been added to the Zacks Rank #5 (Strong Sell) List on June 25, 2024.
Sunoco and Adient's have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Sunoco and Adient's are part of the Zacks Bull and Bear of the Day article.
Bear of the Day: Adient (ADNT)
by Shaun Pruitt
Investors hoping for a rebound in Adient's (ADNT) stock may be disappointed given the downward trend of earnings estimate revisions which still suggests more short-term weakness ahead
New Strong Sell Stocks for June 17th
by Zacks Equity Research
ADNT, ARCB and CIVB have been added to the Zacks Rank #5 (Strong Sell) List on June 17, 2024.
New Strong Sell Stocks for June 6th
by Zacks Equity Research
ADNT, CALB and CTRE have been added to the Zacks Rank #5 (Strong Sell) List on June 6, 2024.
New Strong Sell Stocks for June 3rd
by Zacks Equity Research
BOOT, CPRI and ADNT have been added to the Zacks Rank #5 (Strong Sell) List on June 3, 2024.
New Strong Sell Stocks for May 21st
by Zacks Equity Research
DDD, ADNT and ALGT have been added to the Zacks Rank #5 (Strong Sell) List on May 21, 2024.
Adient (ADNT) Q2 Earnings Beat Estimates, Guidance Revised
by Zacks Equity Research
Adient (ADNT) reports mixed fiscal second-quarter results and expects fiscal 2024 revenues in the range of $14.8-$14.9 billion, down from the previous guidance of $15.40-$15.50 billion.
New Strong Sell Stocks for May 13th
by Zacks Equity Research
AESI, AEG and ADNT have been added to the Zacks Rank #5 (Strong Sell) List on May 13, 2024.
Adient (ADNT) International Revenue Performance Explored
by Zacks Equity Research
Review Adient's (ADNT) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
Compared to Estimates, Adient (ADNT) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Adient (ADNT) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Adient (ADNT) Beats Q2 Earnings Estimates
by Zacks Equity Research
Adient (ADNT) delivered earnings and revenue surprises of 38.46% and 2.15%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Adient (ADNT) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Adient (ADNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Autoliv, Inc. (ALV) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Autoliv (ALV) delivered earnings and revenue surprises of 12.86% and 1.58%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Is Adient (ADNT) Up 5.1% Since Last Earnings Report?
by Zacks Equity Research
Adient (ADNT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Adient (ADNT) Q1 Earnings Miss Estimates, Guidance Revised
by Zacks Equity Research
Adient (ADNT) reports lower-than-expected first-quarter results and envisions fiscal 2024 revenues in the range of $15.40-$15.50 billion, down from the previous guidance of $15.60-$15.70 billion.
Adient (ADNT) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Adient (ADNT) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
What Analyst Projections for Key Metrics Reveal About Adient (ADNT) Q1 Earnings
by Zacks Equity Research
Evaluate the expected performance of Adient (ADNT) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.